Nuvectis Pharma logo

Nuvectis Pharma Share Price Today

(NASDAQ: NVCT)

Nuvectis Pharma share price is $6.35 & ₹552.25 as on 6 Mar 2025, 2.30 'hrs' IST

$6.35

0.01

(0.16%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Nuvectis Pharma share price in Dollar and Rupees. Guide to invest in Nuvectis Pharma stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Nuvectis Pharma, along with analyst recommendations, forecasts, and comprehensive financials.

Nuvectis Pharma share price movements

  • Today's Low: $6.16
    Today's High: $6.48

    Day's Volatility :4.93%

  • 52 Weeks Low: $4.44
    52 Weeks High: $12.10

    52 Weeks Volatility :63.31%

Nuvectis Pharma (NVCT) Returns

PeriodNuvectis Pharma IncIndex (Russel 2000)
3 Months
33.19%
0.0%
6 Months
2.92%
0.0%
1 Year
-35.57%
0.0%
3 Years
-18.51%
-11.6%

Nuvectis Pharma (NVCT) Key Statistics

in dollars & INR

Previous Close
$6.34
Open
$6.4
Today's High
$6.4792
Today's Low
$6.16
Market Capitalization
$148.3M
Today's Volume
$8.7K
52 Week High
$12.1
52 Week Low
$4.44
Revenue TTM
$0.0
Earnings Per Share (EPS)
$-1.11
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-173.41%

How to invest in Nuvectis Pharma Stock (NVCT) from India?

It is very easy for Indian residents to invest directly in Nuvectis Pharma from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Nuvectis Pharma stock in both Indian Rupees (INR) and US Dollars (USD). Search for Nuvectis Pharma or NVCT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Nuvectis Pharma or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Nuvectis Pharma shares which would translate to 0.137 fractional shares of Nuvectis Pharma as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Nuvectis Pharma, in just a few clicks!

Returns in Nuvectis Pharma (NVCT) for Indian investors in Rupees

The Nuvectis Pharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Nuvectis Pharma investment value today

Current value as on today

₹69,495

Returns

₹30,505

(-30.5%)

Returns from Nuvectis Pharma Stock

₹35,467 (-35.47%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Nuvectis Pharma (NVCT)

-61%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Nuvectis Pharma Stock from India on INDmoney has decreased by -61% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Nuvectis Pharma

  • Baldwin Brothers Inc

    1.52%

  • Vanguard Group Inc

    1.39%

  • Marshall Wace Asset Management Ltd

    0.53%

  • Geode Capital Management, LLC

    0.34%

  • BlackRock Inc

    0.27%

  • Forbes J M & Co

    0.25%

Analyst Recommendation on Nuvectis Pharma

Buy

    88%Buy

    11%Hold

    0%Sell

Based on 9 Wall street analysts offering stock ratings for Nuvectis Pharma(by analysts ranked 0 to 5 stars)

Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
8
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Nuvectis Pharma Stock (NVCT)

What analysts predicted

Upside of 191.34%

Target:

$18.50

Current:

$6.35

Insights on Nuvectis Pharma Stock (Ticker Symbol: NVCT)

  • Price Movement

    In the last 3 months, NVCT stock has moved up by 33.2%
  • NVCT vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 100.1%
  • NVCT vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 63.5%

Nuvectis Pharma Technicals Summary

Sell

Neutral

Buy

Nuvectis Pharma is currently in a neutral trading position according to technical analysis indicators.

Nuvectis Pharma (NVCT) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Nuvectis Pharma Inc logo
-6.76%
2.92%
-35.57%
-18.51%
95.08%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Nuvectis Pharma Inc logo
NA
NA
NA
0.0
-1.73
-0.66
NA
0.5
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Nuvectis Pharma Inc logo
Buy
$148.3M
95.08%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Nuvectis Pharma

Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. The company's lead product candidate is NXP800, a novel small molecule that is in Phase 1b clinical trials for the treatment of patients with platinum-resistant, ARID1a-mutated ovarian carcinoma. It is also developing NXP900, a small molecule drug candidate, which is in Phase 1a clinical trails that inhibits the Proto-oncogene c-Src and YES1 kinases. It has license agreement with the CRT Pioneer Fund for the NXP800 and any of related derivatives; and the University of Edinburgh for the NXP900 and any of associated derivatives. The company was formerly known as Centry Pharma, Inc. and changed its name to Nuvectis Pharma, Inc. in July 2021. Nuvectis Pharma, Inc. was incorporated in 2020 and is based in Fort Lee, New Jersey.
Organization
Nuvectis Pharma
Employees
0
CEO
Mr. Ron Bentsur M.B.A.
Industry
Miscellaneous

Management People of Nuvectis Pharma

NameTitle
Mr. Ron Bentsur M.B.A.
Co-Founder, Chairman, CEO & President
Dr. Enrique Poradosu Ph.D.
Co-Founder, Executive VP, Chief Scientific & Business Officer
Mr. Shay Shemesh
Co-Founder, Executive VP, Chief Development & Operations Officer
Mr. Michael Carson CPA
Vice President of Finance

Important FAQs about investing in NVCT Stock from India :

What is Nuvectis Pharma share price today?

Nuvectis Pharma share price today stands at $6.35, Open: $6.40 ; Previous Close: $6.34 ; High: $6.48 ; Low: $6.16 ; 52 Week High: $12.10 ; 52 Week Low: $4.44.

The stock opens at $6.40, after a previous close of $6.34. The stock reached a daily high of $6.48 and a low of $6.16, with a 52-week high of $12.10 and a 52-week low of $4.44.

Can Indians buy Nuvectis Pharma shares?

Yes, Indians can invest in the Nuvectis Pharma (NVCT) from India.

With INDmoney, you can buy Nuvectis Pharma at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Nuvectis Pharma at zero transaction cost.

How can I buy Nuvectis Pharma shares from India?

It is very easy to buy Nuvectis Pharma from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Nuvectis Pharma (NVCT) be purchased?

Yes, you can buy fractional shares of Nuvectis Pharma with INDmoney app.

What are the documents required to start investing in Nuvectis Pharma stocks?

To start investing in Nuvectis Pharma, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Nuvectis Pharma Stock (NVCT)?

Today’s highest price of Nuvectis Pharma (NVCT) is $6.48.

Today’s lowest price of Nuvectis Pharma (NVCT) is $6.16.

What is today's market capitalisation of Nuvectis Pharma?

Today's market capitalisation of Nuvectis Pharma NVCT is 148.3M

What is the 52 Week High and Low Range of Nuvectis Pharma Stock (NVCT)?

  • 52 Week High

    $12.10

  • 52 Week Low

    $4.44

What are the historical returns of Nuvectis Pharma (NVCT)?

  • 1 Month Returns

    -6.76%

  • 3 Months Returns

    2.92%

  • 1 Year Returns

    -35.57%

  • 5 Years Returns

    95.08%

Who is the Chief Executive Officer (CEO) of Nuvectis Pharma ?

Mr. Ron Bentsur M.B.A. is the current Chief Executive Officer (CEO) of Nuvectis Pharma.